<DOC>
	<DOCNO>NCT00630344</DOCNO>
	<brief_summary>The goal clinical trial learn study drug RAD001 combination Bicalutamide slow growth prostate cancer . The safety RAD001 give together Bicalutamide also study . RAD001 show kill prostate cancer cell . In addition , several hundred kidney heart transplant patient treat main ingredient RAD001 many year .</brief_summary>
	<brief_title>RAD001 Bicalutamide Androgen Independent Prostate Cancer</brief_title>
	<detailed_description>- Participants give study medication-dosing calendar treatment cycle . Each treatment cycle last four week time participant take RAD001 bicalutamide orally , per day . RAD001 provide research pharmacy hospital prescription give bicalutamide obtain local pharmacy . - A history , physical exam , blood test perform every four week . An assessment tumor Chest CT scan , chest x-ray , bone scan , abdomen/pelvis CT MRI perform every 12 week .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>18 year age old Histologically document prostate cancer Castration resistant prostate cancer define two rise PSAs castration therapy Baseline PSA 2ns/mL great Testosterone 50ng/mL less Patients LHRH agonist/antagonist must continue therapy recommend dosing interval Prior bicalutamide allow long treatment 6 month longer Metastatic disease require Minimum four week since major surgery , completion radiation , completion prior systemic anticancer therapy ECOG Performance Status equal less 2 Adequate bone marrow liver function outline parameter protocol Prior treatment investigational drug within precede 4 week Prior treatment mTOR inhibitor Fasting lipids parameter outline protocol Chronic treatment systemic steroid another immunosuppressive agent Patients receive immunization attenuate live vaccine study period within one week study entry Uncontrolled brain leptomeningeal metastasis , include patient continue require glucocorticoid brain leptomeningeal metastases Other malignancy within past 3 year except adequately treat basal squamous cell carcinoma skin Patients severe and/or uncontrolled medical condition condition could affect participation study Known history HIV seropositivity Impairment gastrointestinal function gastrointestinal disease may significantly alter absorption RAD001 Patients active , bleed diathesis oral antivitamin K medication ( except low dose coumarin ) Men able conceive unwilling practice effective method birth control Known hypersensitivity RAD001 rapamycins excipients History noncompliance medical regimen</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>RAD001</keyword>
	<keyword>bicalutamide</keyword>
	<keyword>androgen independent prostate cancer</keyword>
</DOC>